tpj12035-sup-0001-FigS1.pptxapplication/346KFigure S1. Accumulation of WRKY45 protein under proteasome inhibition.
tpj12035-sup-0002-FigS2.pptxapplication/25KFigure S2. The transcript level of myc:WRKY45 is unchanged by proteasome inhibition.
tpj12035-sup-0003-FigS3.pptxapplication/994KFigure S3. Localization of the WRKY45:GFP fusion protein in the nucleus.
tpj12035-sup-0004-FigS4.pptxapplication/151KFigure S4. Effect of BTH treatment on the protein level of myc:WRKY45.
tpj12035-sup-0005-FigS5.pptxapplication/1303KFigure S5. The transactivation domain of WRKY45 is located at the C-terminus.
tpj12035-sup-0006-FigS6.pptxapplication/197KFigure S6. WRKY45 is phosphorylated.
tpj12035-sup-0007-TableS1.docxWord document25KTable S1. Primers used for quantitative PCR.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.